Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA

31 Oct 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Vector-Borne Animal Diseases
Share to Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25454873
DOI: 10.1016/j.vaccine.2014.10.033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVAPMID 25454873Read ↗

The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVASemantic proximity Read ↗

Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2Semantic proximity Read ↗

Towards SARS-CoV-2 serotypes?Semantic proximity Read ↗

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue VirusSemantic proximity Read ↗

Development of a gene-deleted live attenuated candidate vaccine against fish virus (ISKNV) with low pathogenicity and high protectionSemantic proximity Read ↗

Understanding the interaction between Betanodavirus and its host for the development of prophylactic measures for viral encephalopathy and retinopathySemantic proximity Read ↗

Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 virusesSemantic proximity Read ↗

Long-Term Protection in Atlantic Salmon (Salmo salar) to Pancreas Disease (Pd) Can Be Achieved Through Immunization with Genetically Modified, Live Attenuated Salmonid Alphavirus 3Semantic proximity Read ↗

Bluetongue virus with mutated genome segment 10 to differentiate infected from vaccinated animals: a genetic DIVA approach.Semantic proximity Read ↗

Analysis of bluetongue serotype 3 spread in Tunisia and discovery of a novel strain related to the bluetongue virus isolated from a commercial sheep pox vaccineSemantic proximity Read ↗

Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challengeSemantic proximity Read ↗

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.